All lobbying firms
THE CONAFAY GROUP, LLC
Registrant on federal lobbying filings · filed 2025 to 2026
$1,670,000
Income reported
19
Clients represented
78
Filings counted
0
Former members lobbying
Clients
19
- DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.) $400,000
- REVAGENIX, INC. $270,000
- CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP $200,000
- REALTA LIFE SCIENCES, INC. $160,000
- BRIGHT PATH LABORATORIES, INC. $120,000
- ELUSYS THERAPEUTICS, INC $120,000
- AGILITI HEALTH INC. $100,000
- LIFESCIENCE LOGISTICS $70,000
- MICROBIOME THERAPEUTICS INNOVATION GROUP (MTIG) $60,000
- ACADIA PHARMACEUTICALS INC. $40,000
- CHILD GENETIC SCREENING ALLIANCE $40,000
- KIRIN BIOMATERIALS $30,000
- ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE $20,000
- VAXXAS INC $20,000
- CRESILON, INC. $10,000
- PKX BIO $10,000
- INTERNATIONAL RETT SYNDROME FOUNDATION $0
- NATIONAL TBI REGISTRY COALITION $0
- SECURING AMERICAS MEDICINES AND SUPPLY SAMS $0
Lobbyists named
3
- DARIN L GARDNER
- BRYAN SHUY
- JOSH NARROW
Reported by year
2 years
- 2026 $710,000
- 2025 $960,000
Issues lobbied
8
Agencies and chambers lobbied
8
- HOUSE OF REPRESENTATIVES
- SENATE
- Health & Human Services, Dept of (HHS)
- Centers For Medicare and Medicaid Services (CMS)
- Executive Office of the President (EOP)
- Food & Drug Administration (FDA)
- Commerce, Dept of (DOC)
- Office of Management & Budget (OMB)
Recent filings
80 total
Q2
KIRIN BIOMATERIALS
Q2
PKX BIO
Q2
CRESILON, INC.
Q2
CHILD GENETIC SCREENING ALLIANCE
Q2
AGILITI HEALTH INC.
Q2
BRIGHT PATH LABORATORIES, INC.
Q2
REVAGENIX, INC.
Q2
REALTA LIFE SCIENCES, INC.
Q2
DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)
Q2
ELUSYS THERAPEUTICS, INC
Q2
ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE
Q2
MICROBIOME THERAPEUTICS INNOVATION GROUP (MTIG)
Q2Y
CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP
RR
KIRIN BIOMATERIALS
RR
PKX BIO
RR
CRESILON, INC.
Q1
BRIGHT PATH LABORATORIES, INC.
Q1
AGILITI HEALTH INC.
Q1
CHILD GENETIC SCREENING ALLIANCE
Q1
REVAGENIX, INC.